Aakaar Medical Technologies Ltd

Fri 4/09/2026,15:32:3 | NSE : AAKAAR

₹62.70-0.30 (-0.48%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 61.30

Previous Close

₹ 63.00

Volume

11200

Mkt Cap ( ₹ Cr)

₹ 88.86

High

₹ 62.90

Low

₹ 61.30

52 Week High

₹ 96.00

52 Week Low

₹ 46.00

Book Value Per Share

₹ 38.49

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Aakaar Medical Technologies Ltd

Your Vote -

Buy

71.43%

Hold

0.00%

Sell

28.57%

71.43%

7 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Aakaar Medical Technologies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Aug 2026, 4:30PM Aakaar Medical Technologies Limited has informed the Exchange about Outcome
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Aug 2026, 12:04PM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Aug 2026, 12:52PM Aakaar Medical Technologies Limited has informed the Exchange about the Cancellation Of Investors Meet which was scheduled to be held on 21.08.26
  • Aakaar Medical Tech - General Updates

    24 Jul 2026, 11:11PM Aakaar Medical Technologies Limited has informed the Exchange about General Updates
  • Aakaar Medical Tech - Updates

    24 Jul 2026, 10:52PM Aakaar Medical Technologies Limited has informed the Exchange regarding 'Board Comments on Notice dated 14.07.2026 from National Stock Exchange'.
  • Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2026, 3:02PM Aakaar Medical Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Jul 2026, 3:13PM Aakaar Medical Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aakaar Medical Tech - Shareholders meeting

    1 Jul 2026, 6:46PM Aakaar Medical Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 30, 2026. Further, the
  • Aakaar Medical Tech - Change in Auditors

    30 Jun 2026, 5:34PM Aakaar Medical Technologies Limited has informed the Exchange regarding Change in Auditors of the company.
  • Aakaar Medical Tech - Amendment to AOA/MOA

    30 Jun 2026, 5:31PM Aakaar Medical Technologies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
  • Aakaar Medical Tech - Shareholders meeting

    30 Jun 2026, 5:27PM Aakaar Medical Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 30, 2026
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Jun 2026, 5:16PM Aakaar Medical Technologies Limited has informed the Exchange about Presentation
  • Aakaar Medical Tech - Reply to Clarification- Financial results

    19 Jun 2026, 11:31AM The Exchange had sought clarification from Aakaar Medical Technologies Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the
  • Aakaar Medical Tech - Copy of Newspaper Publication

    6 Jun 2026, 12:50PM Aakaar Medical Technologies Limited has informed the Exchange about Copy of Newspaper Publication
  • Aakaar Medical Tech - Shareholders meeting

    5 Jun 2026, 12:35PM Aakaar Medical Technologies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 30, 2026

Key fundamentals

Evaluate the intrinsic value of Aakaar Medical Technologies Ltd stock 

Name March-26 March-25 March-24
Assets 73.0849 45.9411 27.5982
Liabilities 73.0849 45.9411 27.5982
Equity 14.1728 10.4224 0.7
Gross Profit 10.3118 9.7369 4.9989
Net Profit 6.6376 6.0395 2.8702
Cash From Operating Activities -8.3613 -5.4063 -8.0441
NPM(%) 9.91 9.8 6.22
Revenue 66.9641 61.5828 46.111
Expenses 56.6523 51.8459 41.1121
ROE(%) 12.16 11.07 5.26

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aakaar Medical Technologies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 860.25 -1.14 21.76 0.00 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 109.43 0.14 1563.29 0.00 0.39 0.00
Vaishali Pharma Ltd 8.32 -0.48 26.00 0.00 15.42 0.00
Astec Lifesciences Ltd 554.45 -3.28 0.00 0.00 -363.14 0.00

Company Info

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Parent Organisation

Aakaar Medical Technologies Ltd.

Founded

20/06/2013

Managing Director

Mr.Rahul Babasaheb Sawakhande

NSE Symbol

AAKAARSM

FAQ